Berg Lise C, Mata Xavier, Thomsen Preben D
Faculty of Life Sciences, Department of Animal and Veterinary Basic Sciences, University of Copenhagen, Groennegaardsvej 7, Frederiksberg C, Copenhagen, Denmark.
Gene. 2008 Jan 15;407(1-2):98-104. doi: 10.1016/j.gene.2007.09.022. Epub 2007 Oct 5.
Cartilage-derived retinoic acid sensitive protein (CD-RAP) also known as melanoma inhibitory activity (MIA) has already been established as a marker for chondrocyte differentiation and a number of cancerous conditions in humans. Studies have also shown that CD-RAP/MIA is a potential marker of joint disease. The objective of this study was to characterize the equine CD-RAP/MIA gene and thus make it available as a marker in cartilage research and clinical studies. Gene analysis revealed that the equine gene (GenBank accession no. EF679787) consists of four exons and three introns, and the homology to the human gene is 90% for the translated region. The upstream sequence includes regulatory elements and putative transcription factor binding sites previously described in the human and murine promoter regions. The deduced amino acid sequence consists of 130 aa including a signal peptide of 23 aa, and has a 91% identity to the human protein. Using radiation hybrid mapping, the CD-RAP/MIA gene was localized to the p arm of equine chromosome 10 (ECA10p), which is in accordance with prediction based on the current human-equine comparative map. Gene expression studies showed expression of CD-RAP/MIA mRNA in articular cartilage and chondrocytes from horses with no signs of joint disease. The expression decreased as the cells dedifferentiated in monolayer culture. We also identified an equine CD-RAP/MIA splice variant similar to that reported in humans. The CD-RAP/MIA protein was detected in equine synovial fluid, serum and culture medium from chondrocyte cultures. In conclusion, CD-RAP/MIA is expressed in equine cartilage and chondrocytes, and the protein can be detected in equine serum, synovial fluid and in culture medium from chondrocyte cultures. The equine gene and resulting protein share great homology with the human gene, making future studies on CD-RAP/MIAs potential as a marker in joint disease possible using the equine joint as a model.
软骨衍生视黄酸敏感蛋白(CD - RAP),也称为黑色素瘤抑制活性蛋白(MIA),已被确立为软骨细胞分化以及人类多种癌症状况的标志物。研究还表明,CD - RAP/MIA是关节疾病的一个潜在标志物。本研究的目的是对马的CD - RAP/MIA基因进行特征分析,从而使其可作为软骨研究和临床研究中的一个标志物。基因分析显示,马的基因(GenBank登录号EF679787)由四个外显子和三个内含子组成,其翻译区域与人类基因的同源性为90%。上游序列包含先前在人类和小鼠启动子区域中描述的调控元件和假定的转录因子结合位点。推导的氨基酸序列由130个氨基酸组成,包括一个23个氨基酸的信号肽,与人类蛋白质的同一性为91%。通过辐射杂交图谱分析,CD - RAP/MIA基因定位于马10号染色体的p臂(ECA10p),这与基于当前人类 - 马比较图谱的预测一致。基因表达研究表明,在没有关节疾病迹象的马的关节软骨和软骨细胞中存在CD - RAP/MIA mRNA的表达。随着细胞在单层培养中去分化,表达下降。我们还鉴定出一种与人类报道的类似的马CD - RAP/MIA剪接变体。在马的滑液、血清以及软骨细胞培养的培养基中检测到了CD - RAP/MIA蛋白。总之,CD - RAP/MIA在马的软骨和软骨细胞中表达,并且该蛋白可在马的血清、滑液以及软骨细胞培养的培养基中检测到。马的基因及其产生的蛋白质与人类基因具有高度同源性,这使得未来有可能以马的关节为模型研究CD - RAP/MIA作为关节疾病标志物的潜力。